SMPD1 and Alzheimer disease: Given this function of ASM, it is reasonable to suggest ASM as a drug target to decrease the ceramide levels critical for Aβ binding of sEVs and therefore effective in both sexes when aiming at ceramide metabolism in AD therapy.